All In Biotech

Free tool

FAERS Monitor: Eligard Kit

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021488 or its brand name (Eligard Kit, Leuprolide Acetate). Reports on generic versions are filed under their own applications.

Reports

53,725

Serious

24,534

46% of reports

Hospitalization

8,120

Death reported

9,258

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • intercepted product preparation error9,289
  • syringe issue7,756
  • death6,647
  • hot flush6,332
  • device leakage6,244
  • wrong technique in product usage process5,489
  • injection site pain4,235
  • fatigue3,553
  • prostatic specific antigen increased1,955
  • asthenia1,692
  • intentional product use issue1,661
  • prostate cancer1,517
  • off label use1,498
  • fall1,455
  • drug ineffective1,324

Reports by year received

View as table
YearReports
200497
2005114
2006109
2007146
2008375
2009202
2010275
2011303
2012417
2013188
2014291
2015847
20162,118
20171,624
20181,701
20192,572
20204,926
20216,196
20227,124
20237,038
20248,802
20255,866
20262,394

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,000,434 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
intercepted product preparation errorSignal9,2891197.91150.82,734,393
syringe issueSignal7,756310.5301.81,334,510
device leakageSignal6,24465.764.0341,168
prostatic specific antigen increasedSignal1,95564.661.6105,015
hot flushSignal6,33235.835.0196,969
wrong technique in product usage processSignal5,48910.910.648,327
intentional product use issueSignal1,6617.57.29,287
prostate cancerSignal1,5177.57.18,420
injection site painSignal4,2355.55.315,464
deathSignal6,6473.03.09,390
fatigue3,5531.81.71,280
asthenia1,6921.81.7568
fall1,4551.71.6438
off label use1,4980.70.6255
drug ineffective1,3240.40.41,325

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.